Join the Contraception group to help and get support from people like you.
Contraception News (Page 5)
Related terms: Contraceptive, Contraception Pill, Contraceptive Pill
FDA Approves Bayer's Kyleena (Levonorgestrel-Releasing Intrauterine System) for Prevention of Pregnancy for up to Five Years
WHIPPANY, N.J., Sept. 19, 2016 /PRNewswire/ – Bayer announced today that the U.S. Food and Drug Administration (FDA) approved Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Three Years
DUBLIN and SAN FRANCISCO, Feb. 27, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical...
Mylan Launches Xulane - First Generic Ortho Evra Patch
PITTSBURGH, April 16, 2014 /PRNewswire/ – Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Xulane (Norelgestromin / Ethinyl Estradiol...
Warner Chilcott Announces FDA Approval of Lo Minastrin Fe
DUBLIN, Ireland, July 25, 2013 – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved Lo Minastrin Fe (norethindrone acetate and ethinyl...
FDA Medwatch Alert: Estarylla (norgestimate and ethinyl estradiol): Recall - Report of Placebo Tablet Present in Row of Active Tablets
ISSUE: Sandoz notified the public it is conducting a voluntary nationwide recall to the retailer level of one lot of its Estarylla (norgestimate and ethinyl estradiol) tablets in the US, following a...
FDA Approves Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
JERUSALEM--(BUSINESS WIRE)--Mar. 29, 2013-- Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Quartette (levonorgestrel/ethinyl...
U.S. FDA Approves Bayer's Skyla (Levonorgestrel-Releasing Intrauterine System) 13.5 mg For Prevention Of Pregnancy For Up To Three Years
WAYNE, N.J., Jan. 9, 2013 /PRNewswire/ – Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Skyla (levonorgestrel-releasing intrauterine...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher risk for blood clots
ISSUE: FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.Based on this review,...
FDA Medwatch Alert: Norgestimate and Ethinyl Estradiol Tablets: Recall - Packaging Error, Potential for Incorrect Dosing Regimen
ISSUE: Glenmark Generics Inc. issued a nationwide, consumer-level recall of seven (7) lots of Norgestimate and Ethinyl Estradiol Tablets USP (0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg),...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
[UPDATED 09/26/2011] FDA has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. FDA...
FDA Medwatch Alert: Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error
includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem, Tri-Previfem ISSUE: Qualitest Pharmaceuticals issued a nationwide, retail-level recall of...
FDA Medwatch Alert: Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
ISSUE: FDA is aware of two newly published studies that evaluated the risk of venous thromboembolism (VTE) in women who use birth control pills that contain drospirenone. The two recently published...
Warner Chilcott Announces FDA Approval of New Oral Contraceptive Lo Loestrin Fe
ARDEE, Ireland, Oct. 22 /PRNewswire-FirstCall/ – Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved Lo Loestrin Fe (norethindrone acetate and...
FDA Approves Beyaz - Combination Contraceptive Containing a Folate
ROCKVIILE, Md., Sept. 24, 2010--The U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium...
Further information
Related condition support groups
Emergency Contraception, Postcoital Contraception
Related drug support groups
Depo-Provera, Nexplanon, Provera, NuvaRing, Mirena, Implanon, levonorgestrel, Sprintec, Loestrin 24 Fe, Yasmin, Lo Loestrin Fe, medroxyprogesterone, Kyleena